A cross-sectional, prospective study analyzing Correlation of Vedolizumab Trough Levels with Clinical and Biochemical Markers in Inflammatory Bowel Disease
Latest Information Update: 18 Feb 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 18 Feb 2020 New trial record